Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Genital Neoplasms, Male × Androgen Antagonists × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 32 Neoplasm Metastasis 3 Adenocarcinoma 2 Triple Negative Breast Neoplasms 1 Stage IV Prostate Adenocarcinoma AJCC v7 1 Salivary Gland Neoplasms 1 Recurrence 1 Prostatic Diseases 1 Prostate Cancer Metastatic 1 Neoplasms 1 Metastatic Hormone Sensitive Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castrate-sensitive Prostate Cancer 1 Lymphatic Metastasis 1 Hormone Sensitive Prostate Cancer 1 Erectile Dysfunction 1 Breast Neoplasms 1 Adenocarcinoma of the Prostate 1

Interventions

2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡